Everbeat is the world’s only wrist-based clinical-grade ECG capable of continuously monitoring cardiovascular health to detect atrial fibrillation (AF). Class 2 FDA clearance for their wearable (+ app) is expected in early 2018. Heart disease is the #1 cause of death in the United States (800,000 people/year) and cardiac care is reactive & event-driven, but Everbeat is developing a solution that is both proactive & continuous.

Close [x]
Sign Up for Our Mailing List
Receive the latest updates from our community and be the first to hear about New lab events and programming.